RecruitingNCT03887715
This study is recruiting in the United States. It is testing VNS Therapy® System for depression.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- LivaNova
- Condition
- Depression
RecruitingNCT06005103
This study is recruiting in Denmark. It focuses on depression.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Denmark
- Sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
- Condition
- Depression
Not Yet RecruitingNCT06894641
This study is not yet recruiting in Global. It focuses on depression.
DepressionBehavioralOver 65 Years
- Countries
- Global
- Sponsor
- Nova Scotia Health Authority
- Condition
- Depression
RecruitingNCT04223115
This study is recruiting in Finland. It is testing digitalized Cognitive Behavioral Intervention for depression.
DepressionBehavioralFrom 18 Years to 55 Years
- Countries
- Finland
- Sponsor
- University of Turku
- Condition
- Depression
Active Not RecruitingNCT07102017
This study is active but not recruiting in China. It focuses on Depression.
DepressionDeviceOver 65 Years
- Countries
- China
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Condition
- Depression
Not Yet RecruitingNCT07482852
This study is not yet recruiting in Global. It focuses on depression.
DepressionOtherFrom 18 Years to 25 Years
- Countries
- Global
- Sponsor
- Hunan University of Traditional Chinese Medicine
- Condition
- Depression
Enrolling By InvitationNCT06383221
This study is enrolling by invitation in China. It focuses on depression.
DepressionOtherOver 18 Years
- Countries
- China
- Sponsor
- Fangbiao Tao
- Condition
- Depression
RecruitingNCT06072898
This study is recruiting in Canada. It focuses on depression.
DepressionOtherFrom 18 Years to 64 Years
- Countries
- Canada
- Sponsor
- Sunnybrook Health Sciences Centre
- Condition
- Depression
RecruitingNCT06906939
This study is recruiting in the United States. It focuses on depression.
DepressionOtherFrom 50 Years to 95 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Depression
RecruitingNCT06775379
This study is recruiting in the United States. It is testing azetukalner Versus Placebo for depression.
DepressionDrugFrom 18 Years to 74 Years
- Countries
- United States
- Sponsor
- Xenon Pharmaceuticals Inc.
- Condition
- Depression
RecruitingNCT07076407
This study is recruiting in multiple countries, including in Finland, in Poland, and in Romania. It is testing azetukalner Versus Placebo for depression.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Finland, Poland, Romania, Slovakia, United States
- Sponsor
- Xenon Pharmaceuticals Inc.
- Condition
- Depression
Not Yet RecruitingNCT07227103
This study is not yet recruiting in the United States. It focuses on depression.
DepressionDrugFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- NeuroRx, Inc.
- Condition
- Depression
Not Yet RecruitingNCT06749470
This study is not yet recruiting in Global. It focuses on depression.
DepressionDrugFrom 18 Years to 65 Years
- Countries
- Global
- Sponsor
- Central South University
- Condition
- Depression
UnknownNCT05526235
This study is looking at whether questionnaires and follow-up can help people with Depression, Anxiety, or Psychological Distress. Participants take part in the program and complete follow-up questionnaires or assessments.
DepressionBehavioralFrom 18 Years to 65 Years
- Countries
- Spain
- Sponsor
- Fundació Sant Joan de Déu
- Condition
- Depression
CompletedNCT05841030
This study is completed in multiple countries, including in Argentina, in Brazil, and in Canada. It focuses on depression.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Argentina, Brazil, Canada, France, Germany, Italy, South Korea, Spain, Sweden, United Kingdom, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
Active Not RecruitingNCT03642964
This study is comparing CTC-501 with placebo for people with depression. Participants receive CTC-501 or placebo and complete study visits and assessments.
DepressionDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Chase Therapeutics Corporation
- Condition
- Depression
TerminatedNCT05518149
This study has public registry information in multiple countries, including in Argentina, in Australia, and in Belgium. It is testing aticaprant for depression.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, United Kingdom, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
RecruitingNCT07412756
This study is recruiting in multiple countries, including in Australia, in Brazil, and in Canada. It is testing brenipatide for depression.
DepressionOtherFrom 18 Years to 75 Years
- Countries
- Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, United States, South Korea, Spain, Taiwan, United Kingdom
- Sponsor
- Eli Lilly and Company
- Condition
- Depression
RecruitingNCT07053345
This study is recruiting in South Korea. It is testing esketamine Nasal Spray for depression.
DepressionOtherFrom 18 Years to 64 Years
- Countries
- South Korea
- Sponsor
- Janssen Korea, Ltd., Korea
- Condition
- Depression
RecruitingNCT05803551
This study is recruiting in the United States. It focuses on Depression.
DepressionDrugFrom 18 Years to 99 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Depression
RecruitingNCT05599126
This study is recruiting in China. It is testing mianserin for depression.
DepressionDrugFrom 18 Years to 60 Years
- Countries
- China
- Sponsor
- Zhenghui YI
- Condition
- Depression
Active Not RecruitingNCT06792136
This study is active but not recruiting in Japan. It is testing ONO-1110 for depression.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Japan
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Condition
- Depression
Enrolling By InvitationNCT07000799
This study is enrolling by invitation in Norway. It is testing School Absenteeism and Student Well-being for Depression.
DepressionBehavioralFrom 8 Years to 13 Years
- Countries
- Norway
- Sponsor
- University of Oslo
- Condition
- Depression
RecruitingNCT07204314
This study is recruiting in Japan. It is testing vortioxetine for depression.
DepressionOtherFrom 12 Years to 17 Years
- Countries
- Japan
- Sponsor
- Takeda
- Condition
- Depression
RecruitingNCT06793397
This study is recruiting in multiple countries, including in Australia, in Czech Republic, and in Germany. It is testing a Deuterated Psilocin Analog for depression.
DepressionOtherFrom 18 Years to 85 Years
- Countries
- Australia, Czech Republic, Germany, Greece, Ireland, Poland, United Kingdom, United States
- Sponsor
- Cybin IRL Limited
- Condition
- Depression